Patents by Inventor David Rasnick

David Rasnick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Irreversible cysteine protease inhibitors containing vinyl groups conjugated to electron withdrawing groups
    Patent number: 6287840
    Abstract: Irreversible cysteine protease inhibitors based upon an alkene bond being conjugated to an electron withdrawing group are disclosed. The inhibitor structure also provides a targeting peptide which is specific for different cysteine proteases. The method of making the inhibitors, and methods of using the inhibitors to inhibit cysteine proteases and for therapy are disclosed.
    Type: Grant
    Filed: August 18, 1999
    Date of Patent: September 11, 2001
    Assignee: Axys Pharmaceuticals, Inc.
    Inventors: James T. Palmer, David Rasnick, Jeffrey Lee Klaus
  • Reversible cysteine protease inhibitors
    Patent number: 6030946
    Abstract: Cysteine protease inhibitors are provided.
    Type: Grant
    Filed: June 3, 1996
    Date of Patent: February 29, 2000
    Assignee: Axys Pharmaceuticals, Inc.
    Inventors: Jeffrey L. Klaus, David Rasnick, James T. Palmer, Elaine Yee-Lin Kuo
  • Irreversible cysteine protease inhibitors containing vinyl groups conjugated to electron withdrawing groups
    Patent number: 5976858
    Abstract: Irreversible cysteine protease inhibitors based upon an alkene bond being conjugated to an electron withdrawing group are disclosed. The inhibitor structure also provides a targeting peptide which is specific for different cysteine proteases. The method of making the inhibitors, and methods of using the inhibitors to inhibit cysteine proteases and for therapy are disclosed.
    Type: Grant
    Filed: August 23, 1996
    Date of Patent: November 2, 1999
    Assignee: Arris Pharmaceuticals
    Inventors: James T. Palmer, David Rasnick, Jeffrey Lee Klaus
  • Reversible protease inhibitors
    Patent number: 5776718
    Abstract: The invention relates to novel reversible protease inhibitors. The inhibitors are specific to cysteine proteases.
    Type: Grant
    Filed: March 20, 1996
    Date of Patent: July 7, 1998
    Assignee: Arris Pharmaceutical Corporation
    Inventors: James T. Palmer, David Rasnick, Jeffrey Lee Klaus